Target- |
MechanismInterleukin-8 receptors antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismalbumin agonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with DMI Biosciences, Inc.
0 Patents (Medical) associated with DMI Biosciences, Inc.
100 Deals associated with DMI Biosciences, Inc.
100 Translational Medicine associated with DMI Biosciences, Inc.